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Copyright © 2005 by The American Asso-
ciation for Thoracic Surgerydoi:10.1016/j.jtcvs.2004.10.018Objectives: We reviewed our experience with repair of truncus arteriosus to assess
the effect of type of right ventricular outflow tract reconstruction on perioperative
morbidity, survival, and freedom from catheter-based interventions and reoperation.
Methods: Patients undergoing repair of truncus arteriosus from June 1990 through
February 2004 were evaluated on the basis of operative procedure regarding
preoperative and postoperative variables, the need for postoperative catheter-based
intervention or reoperation, and survival on the basis of univariate, multivariable,
and actuarial analyses.
Results: Of 54 study patients, 15 (28%) received a valved homograft, and 39 (72%)
received a direct connection with a variety of hood materials. Five (9.1%) patients died.
Valved homograft recipients were more likely to require reoperation than patients
receiving direct connections (40% vs 15%, P  .046); however, valved homograft and
direct connection recipients had a similar incidence of the combined end point of
reoperation or catheter-based intervention (40.0% vs 37.5%, P .865). Univariate and
multivariable modeling demonstrated use of valved homografts or direct connections
with an autologous pericardial hood to be predictive of the need for later catheter-based
intervention or reoperation. Actuarial analysis demonstrated a trend toward improved
outcomes in the direct connection group and within the direct connection cohort, a
statistically significant difference on the basis of hood type.
Conclusions: Although the direct connection technique might not prevent later catheter-
based intervention, it does reduce the need for reoperation. Outcomes among direct
connection recipients were associated with hood type: polytetrafluoroethylene hoods
(W. L. Gore & Associates, Inc, Tempe, Ariz) had the lowest rate of reintervention, and
untreated autologous pericardial hoods had the highest rate of reintervention. We report
excellent outcomes with primary repair of truncus arteriosus. Where anatomically
appropriate, we advocate the direct connection technique.
Since the first report of successful surgical correction of truncus arte-riosus (TA) in 1965, several advances have favorably affected overallresults.1 Although the tenets of the repair have not changed substan-tially over time, considerable debate persists as to the best method toestablish right ventricle (RV)–pulmonary artery (PA) continuity. Tra-ditional techniques have favored the use of valved homografts (VHs),
accepting with it the obligatory need for later replacement. More recently, others
have promoted the so-called direct connection (DC), which obviates the need for
allograft tissue by directly anastomosing the RV to the PA confluence.2,3
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DIn theory, the DC technique preserves the potential for
growth by using the patient’s own tissue for the repair.
Several materials have been applied to complete the hood of
the connection in an attempt to limit the distortion of branch
PAs and to allow for an unobstructed right ventricular
outflow tract (RVOT). Although it has been suggested that
the DC might reduce the need for later reoperation, whether
this technique actually abolishes the need for reoperation or
instead replaces it with other catheter-based interventions
(CBIs; eg, stent placement and balloon angioplasty) remains
unclear.
We evaluated our experience with primary repair of TA
both with VH conduits and with DC using a variety of hood
materials. In so doing, we sought to evaluate our evolving
experience and to assess the effect of type of RVOT recon-
struction on perioperative morbidity, survival, and freedom
from CBI and reoperation.
Methods
Patients
We reviewed the records of all patients undergoing primary repair
of TA from June 1990 through February 2004 at the Children’s
Hospital of New York. For the purposes of analysis, 4 other
Figure 1. Schematic representation of the trapdoor incision used
to bridge the distance between the pulmonary arteriotomy and
the top of the right ventriculotomy. The door forms the back wall
of the DC in this arrangement.children who had undergone their first repair at other institutions
560 The Journal of Thoracic and Cardiovascular Surgery ● Marand patients with hemitruncus were not included. Functional and
demographic parameters evaluated included age, associated ana-
tomic anomalies, DiGeorge syndrome, preoperative truncal valve
morphology and function, operative procedure, need for postoper-
ative CBI (balloon or stent) or reoperation and most recent echo-
cardiogram. Survival and late functional data were based on
follow-up with referring cardiologists and, where indicated, direct
telephone interview.
Operative Procedure
Repair of TA was performed with hypothermic cardiopulmonary
bypass and occasionally with deep hypothermic circulatory arrest
when aortic arch repair was required. Cold blood cardioplegia was
used for myocardial protection, with topical cold saline or ice
slush.
VH technique (15 patients). The PAs were excised carefully
from the ascending aorta. The defect in the ascending aorta was
then closed with a polytetrafluoroethylene (PTFE) patch (Gore-
Tex patch; W. L. Gore & Associates, Inc, Tempe, Ariz). A vertical
right ventriculotomy was then performed, and the ventricular sep-
tal defect was closed, again with a PTFE patch. RV-PA continuity
was then established with a VH in 15 patients; in 7 patients this
was a pulmonary homograft, and in 8 it was an aortic homograft.
Aortic homograft sizes ranged from 9 to 11 mm, whereas all but 2
pulmonary homografts (which were 9 and 11 mm) were downsized
from larger (21-24 mm) to smaller (12-16 mm) sizes; in these
grafts valve competency was preserved. The conduit was anasto-
mosed first to the PA and then was anastomosed posteriorly to the
RV by using a hood over the anterior portion to prevent distortion;
for aortic homografts, the hood was comprised of mitral valve
tissue, and for pulmonary homografts, the hood was comprised of
PA homograft tissue.
DC technique (40 patients). An incision was made in the
truncus just left of midline so as not to compromise the aortic
lumen. The truncal valve was inspected, and the defect was closed
as above. The PAs, however, were left in situ; if the pulmonary
arteriotomy was immediately adjacent to the upper portion of the
right ventriculotomy, often the small portion of epicardium bridg-
ing this distance was used as the back wall of the DC. In other
cases, a trapdoor-type incision was made in the PA and turned
down toward the ventricle to bridge the distance between the PA
and the RV (Figure 1). Several materials were used to reconstruct
the anterior hood so as to prevent PA distortion or RVOT
obstruction.
Postoperative Interventions
Indications for postoperative CBI are also in evolution. With the
increasing recognition of the potential problems of RVOT or
branch PA stenosis with either method of repair, our threshold to
intervene has been substantially reduced. Our indications currently
include the following: (1) persistently increased RV pressures
(greater than two thirds systemic); (2) persistent right-to-left shunt-
ing and subsequent cyanosis in the setting of increased RV pres-
sures; (3) substantial PA distortion (near occlusion) with risk of
loss of branch PA flow; or (4) evidence of substantial disparity in
pulmonary blood flow (by means of quantitative magnetic reso-
nance imaging assessment or by means of radionucleotide perfu-
sion scanning) associated with significant branch PA stenosis.
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above parameters with CBI or mild-to-moderate right-sided ob-
struction in a patient undergoing other cardiac procedures (eg,
truncal valve replacement). Our indications for truncal valve re-
placement involve progressive and severe truncal insufficiency or
stenosis with resultant left ventricular hemodynamic compromise.
Echocardiography
Perioperative and late postoperative transthoracic echocardiogra-
phy was obtained to establish parameters of anatomy and ventric-
ular function. Specifically, the degree of truncal valve insuffi-
ciency or stenosis, descending aortic Doppler flow, RVOT
obstruction, pulmonary insufficiency, parameters of ventricular
function and dilation, evidence of residual ventricular septal de-
fects, and evidence of branch PA stenosis was evaluated. RVOT
and PA obstruction, when present, were graded according to the
following scale measuring peak gradients: mild, less than 40 mm
Hg; moderate, 40-60 mm Hg; and severe, greater than 60 mm Hg.
Statistical Analysis
Statistical methods were used to identify and estimate risk factors
predicting the incidence of interventions (catheter-based, opera-
tive, or any intervention), as well as intervention-free survival. The
methods of statistical analysis included the following: 2 test for
comparisons of dichotomous risk factors with negative outcomes,
TABLE 1. Reoperations for right-sided obstruction in the t
Patient Age First repair
1 13 d Direct connection (autologous pericardiu
2 38 d Direct Connection (autologous pericardiu
3 30 d 9-mm Aortic homograft
4 11 d Direct connection (autologous pericardiu
5 4 d 9-mm Aortic homograft–interrupted aortic
arch
6 21 d Direct connection (autologous pericardiu
7 48 d 10-mm Aortic homograft
8 12 d Direct connection (bovine pericardium)
9 14 d 9-mm Aortic homograft–interrupted aortic
arch, PFO
10 23 d Direct connection (bovine pericardium)
11 7 d 10-mm Aortic homograft
12 6 d 9-mm Pulmonary homograft–double aorti
arch
RVOT, Right ventricular outflow tract; PA, pulmonary artery; RPA, right puMantel-Haenszel 2 test for comparisons taking into consideration
The Journal of Thoracirisk factor severity (eg, degree of valvular incompetence), and
Wilcoxon test for comparisons of continuous variables with neg-
ative outcomes (P  .05).
Logistic regression analysis of the cumulative incidence of
interventions was used to evaluate the influence of these risk
factors in a multivariable manner. Life-table estimates (Kaplan-
Meier) were calculated by using the LIFETEST procedure of SAS
6.12 for PowerPC (SAS Institute, Cary, NC), with the log-rank test
for difference between strata. The Cox regression model (using the
PHREG procedure) was used to identify the most predictive vari-
ables. After univariate analysis, variables were entered into the
models by using 3 selection criteria: forward, forward stepwise,
and backward. The following variables were evaluated as follows:
homograft, PTFE hood, bovine pericardium, autologous pericar-
dium, cryopreserved pericardium, degree of valvular incompe-
tence, year of operation, and age. Models were compared by using
the2 Log L score and the Wald score for significance. Threshold
for entry into the model for both logistic regression and Cox
regression was a P value of less than .05. This study received
approval by the institutional review board.
Results
Patients
Between June 1990 and February 2004, 54 patients under-
us cohort
Interval Reoperation
9 d Revision of RVOT (obstruction) with autologous
pericardium
2.9 mo Revision of outflow patch (aneurysmal) with
bovine pericardium
3.8 mo Conduit replacement (downsized pulmonary
homograft) for conduit obstruction
5 mo Revision of outflow patch (aneurysmal) with
PTFE, repair PA bifurcation
5.7 mo Truncal valve repair, repair RPA stenosis,
repair supravalvar stenosis
9.6 mo Repair of RPA stenosis, resection of
homograft, direct connection (PTFE hood)
6.2 mo Revision of outflow patch (aneurysmal) with
PTFE, repair of LPA
7.5 mo Conduit replacement (15-mm aortic homograft),
repair LPV stenosis, repair RPA stenosis
2.4 y Repair of RPA stenosis (PTFE)
6.9 y Repair of RVOT (PTFE) for stenosis
2.6 y Conduit replacement (15-mm aortic homograft)
3.7 y Repair origin of LPA and RPA (autologous
pericardium)
6.8 y Conduit replacement (21-mm aortic homograft),
repair branch PA stenosis
8.9 y Conduit replacement (16-mm pulmonary
homograft)
ry artery; LPA, left pulmonary artery; LPV, left pulmonary vein.runc
m)
m)
m)
m)
cwent primary repair of TA at the Children’s Hospital of
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DNew York. Of the 54 study patients, 15 (28%) underwent
VH repair, and 39 (72%) underwent DC repair with a
variety of hood materials to establish RV-PA continuity.
One additional patient, who initially underwent repair with
a VH conduit, ultimately underwent reoperation 10 months
later and was converted to DC repair; all data after her
reoperation were assigned to the DC cohort beginning at
that time point.
The median age of the VH cohort was 16 days (range,
4-159 days), and that of the DC cohort was 13 days (range,
4-132 days). Truncus types according to the Collett-Edwards
TABLE 2. Catheter-based interventions in the truncus arte
Patient Age Operation Int
1 30 d 9-mm Aortic homograft 3.8
2 13 d Direct connectionautologous
pericardium3reoperation 9 d
later for RVOT obstruction
3.8
3 7 d 12-mm Aortic homograft 6.3
4 11 d Direct connectionautologous
pericardium
7.3
5 16 d Direct connectioncryopreserved
pericardium
7.4
6 4 d Direct connectioncryopreserved
pericardium
7.5
7 48 d 10-mm Aortic homograft 9
8 22 d Direct connectionPTFE 1.6
9 14 d 9-mm Aortic homograft 1.7
10 23 d Direct connectionbovine
pericardium
1.7
11 11 d Direct connectionautologous
pericardium3reoperation 5 mo
later for aneurysmal dilatation
of patch
2.1
12 10 d 11-mm Aortic homograft 3.6
13 19 d Direct connectionbovine
pericardium
5.3
14 29 d Direct connectionbovine
pericardium
6.7
15 14 d Direct connectionbovine
pericardium
6.8
16 14 d Direct connectionPTFE 7.4
17 38 d Direct connectionautologous
pericardium3reoperations 2.9
mo later for aneurysmal
dilatation of patch
8.2
18 8 d Direct connectionPTFE 8.5
RVOT, Right ventricular outflow tract; LPA, left pulmonary artery; PA, pulmclassification were type I (n  17 [31.5%]), type II (n  10
562 The Journal of Thoracic and Cardiovascular Surgery ● Mar[18.5%]), transitional between types I and II (n 23 [42.6%]),
and type III (n 4 [7.4%]). Associated lesions included patent
foramen ovale–secundum atrial septal defect in 9 patients,
anomalous coronary arteries in 8 patients (most often a single
coronary artery), double aortic arch in 2 patients, and inter-
rupted aortic arch in 6 patients (3 VH recipients and 3 DC
recipients). DiGeorge syndrome was definitively diagnosed in
6 patients (2 VH recipients and 4 DC recipients).
Patients were followed for a median of 4.6 years (range,
0-12.2 years). Thirteen patients were lost to follow-up after a
median of 1.6 years (range, 7 days to 7.1 years), and these
s cohort
Intervention Reintervention
RVOT balloon Conduit stent 1.2 y later
LPA balloon-stent Bilateral branch PA balloon
angioplasty 4.6 mo later
RPA and LPA balloon RPA-LPA balloon 4.6 mo
later3RPA balloon 9.5 mo
later3reoperation 5.1 y later
conduit replacement, RPA-
LPA patch angioplasty
RPA balloon
RPA stent
LPA balloon-stent LPA stent 8.8 mo later3LPA
balloon 16.6 mo later
LPA balloon Conduit replacement 1 d later,
LPV repair
RVOT balloon
RPA stent Balloon 8.6 mo3conduit
replacement 49 d later
RVOT balloon Reoperation 2 y laterbilateral
PA patch angioplasty
LPA stent Bilateral branch PA stent 2.9 y
later, bilateral balloon
angioplasty 1 y later
RPA balloon
LPA stent
RPA stent
RPA and LPA stent
RPA balloon
RPA and LPA stent
RVOT balloon
y artery; RPA, right pulmonary artery; LPV, left pulmonary vein.riosu
erval
mo
mo
mo
mo
mo
mo
mo
y
y
y
y
y
y
y
y
y
y
yincluded 3 VH recipients and 10 DC recipients. Total
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Dfollow-up (mean, median, range) for DC recipients was 1781,
1749, and 0 to 4128 days, respectively, and that for VH
recipients was 1957, 1656, and 0 to 4449 days, respectively (P
 .6985). Overall, 17 (30.9%) patients required a CBI, 12
(21.8%) required reoperation for right-sided obstruction, and
21 (38.2%) required either CBI or reoperation during the
follow-up period.
Operative Procedure
Several hood materials were used for the DC as follows:
autologous pericardium, 6 (15%); bovine pericardium, 8
(20%); cryopreserved pericardium, 7 (18%); PTFE, 14
(35%); and other, 5 (12%; 3 homograft nonvalved PAs and
2 unknown). No patient underwent repair of the truncal
valve at the time of the operation. Additional procedures
performed at the time of truncus repair included the follow-
ing: repair of interrupted aortic arch, 6 (11%); closure of
patent foramen ovale or secundum atrial septal defect, 5
(9.2%); and division of double aortic arch, 2 (4%). Seven
VH recipients and 7 DC recipients required reoperation; 3
patients (2 DC recipients and 1 VH recipients) required
reoperation solely for truncal valve insufficiency and not for
right-sided obstruction. These patients were censored from
survival analysis addressing freedom from right-sided inter-
ventions at the time of their reoperation for truncal valve
replacement. The specifics of the procedures performed for
right-sided obstruction are collected in Table 1 (reopera-
tions) and Table 2 (CBI).
Echocardiography
Thirty-six patients had echocardiographic follow-up within
2 years of the study’s end. Although many patients had been
seen more recently and often for more than 5 years of total
follow-up, their echocardiographic data was not included in
the analysis unless it was obtained within 2 years of the
study termination date.
Truncal valve. Nine (25%) patients had minimal, 15
(42%) had mild, and 9 (25%) had moderate truncal insuf-
TABLE 3. Mortality in the truncus arteriosus cohort
Patient Age at repair Operation
1 10 d DC (cryopreserved pericardium)
2 18 d DC (homograft patch)
3 20 d Pulmonary homograft
4 4 d Pulmonary homograft POD 1
5 69 d Pulmonary homograft
DC, Direct connection; POD, postoperative day; RV, right ventricular.ficiency; all patients with mild or less truncal valve insuf-
The Journal of Thoracificiency had normal descending aortic Doppler measure-
ments. Two (5.5%) patients had mild truncal valve stenosis
(peak gradients of 21 and 36 mm Hg, respectively).
VH recipients. Of the 9 VH recipients for whom data
were available, 3 (33%) had minimal-to-mild RVOT ob-
struction, and 6 (67%) had moderate RVOT obstruction.
Five (56%) had minimal-to-mild, 1 (11%) had moderate,
and 3 (33%) had severe pulmonary insufficiency. All had
normal ventricular function, and none had residual ventric-
ular septal defects. Four (44%) patients were free of and 5
(56%) had mild branch PA stenosis.
DC recipients. Of the 27 DC recipients for whom data
were available, 19 (70%) had minimal-to-mild, 7 (26%) had
moderate, and 1 (4%) had severe RVOT obstruction. All
were free of pulmonary insufficiency. All had normal ven-
tricular function, and 2 had small residual ventricular septal
defects. Eighteen (67%) patients were free of branch PA
stenosis, and 7 (26%) had mild and 2 (7%) had moderate
branch PA stenosis. Of those patients free of branch PA
stenosis or obstruction, 5 had undergone a prior CBI (3
underwent balloon angioplasty and 2 underwent stent
placement).
Morbidity and Mortality
Five (9.1%) patients died postoperatively, and their data are
collected in Table 3. Of particular note, 3 of the 5 deaths
occurred before 1995, and the other 2 occurred in 1996 and
1999. With the exception of patient 5, who died late after
repair, many of the deaths involved pulmonary hyperten-
sion. In addition to the major morbidities of reoperation and
CBI, 2 patients required delayed sternal closure, and 2
additional patients had complete heart block requiring per-
manent pacemaker placement 9 months and 9.2 years after
truncus repair, respectively.
Outcomes
Results are represented below for each of the outcomes
studied (reoperation, CBI, and any intervention) in the fol-
Interval Cause
0 Biventricular failure
0 Pulmonary hypertension/left upper lobe
pneumonia
1 Pulmonary hypertension/right lower lobe
pneumonia/low output
onary hypertension/
failure
Sepsis/heart failure/medication
noncompliancePOD
POD
POD
Pulm
RV
7 molowing fashion: incidence of intervention in VH versus DC
c and Cardiovascular Surgery ● Volume 129, Number 3 563
for p
Surgery for Congenital Heart Disease Chen et al
CH
Drecipients, univariate analysis on the basis of hood type,
Kaplan-Meier estimates of intervention-free survival (strat-
ified by operation type and hood type), and results of
regression modeling of both overall incidence (logistic re-
gression) and intervention-free survival (Cox proportional
hazards). Results comparing hood types are reported com-
paring each type of hood with all other patients, including
those receiving VHs; additional analysis was performed
comparing hoods only among those receiving DCs, and the
results were similar and not reported below.
Reoperation. VH recipients were more likely to require
reoperation than DC recipients (40% vs 15%, P  .046).
Among the DC recipients there was significant variation
between reoperation rates. At the extremes, no patients (0%
vs 29.4% for all others, P  .046) with a PTFE hood
required reoperation compared with 4 (66.7% vs 16.3% for
all others, P  .005) of those with autologous pericardial
hoods. The incidence of reoperation in the groups was as
follows: bovine pericardium, 2 (P  .814); cryopreserved
pericardium, 0 (P  .170); PTFE, 0 (P  .022); and other,
0 (P  .170).
Kaplan-Meier estimates of survival free from reoperation
Figure 2. Kaplan-Meier survival function of freedom fro
hood type. Five-year survival estimates are illustratedwere similar in both the DC and VH groups, although there
564 The Journal of Thoracic and Cardiovascular Surgery ● Marwas a trend toward improved reoperation-free survival
among those with DCs (P  .0713). However, among
patients receiving DCs, there was a significant difference
according to hood type (P  .0003, Figure 2); in this
analysis bovine pericardium, cryopreserved pericardium,
and “other” (most often PA homograft tissue) were com-
bined as a group. Factors predictive of need for earlier
reoperation on the basis of a Cox model are compiled in
Table 4. A logistic regression model predicting need for
reoperation identified identical risk factors.
CBI. The incidence of CBI was similar among VH
recipients (26.7% [4/15]) and DC recipients (32.5% [13/40];
P  .677). Patients undergoing reconstruction with autolo-
gous pericardial hoods were more likely to require CBI
(66.7% [4/6] vs 26.5% for all others, P  .045). No other
significant differences were noted: bovine pericardium, 4 of
8 (50%, P  .206); cryopreserved pericardium, 2 of 6
(P  .892); PTFE, 3 of 14 (P  .374); and other, 0 of 6
(P  .083). No specific preoperative anatomic diagnosis,
demographic parameter, year, or operation or adjunctive
operative procedure predicted the need for later CBI.
Neither univariate nor multivariable analyses demon-
operation for only those DC recipients, as stratified by
atients as a function of type of DC (P  .0003).m restrated a predictor of the need for later CBI, and Kaplan-
ch 2005
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difference between the VH and DC cohorts or among the
different hood types of DC recipients. Neither logistic re-
gression nor Cox multivariable modeling demonstrated sig-
nificant predictors of earlier CBI.
Any intervention (reoperation or CBI). VH and DC
recipients had similar incidences of the combined end point
of reoperation or CBI (40.0% [6/15] vs 37.5% [15/40],
P  .865). Those patients receiving autologous pericardial
hoods were more likely to need intervention than all others
(83.3% [5/6] vs 32.6%, P  .041), whereas those in the
other category were significantly less likely to need inter-
vention compared with all others (0.0% [0/6] vs 42.9%).
The incidence of intervention for other types of DCs
showed a trend toward decreased rates with PTFE hoods:
bovine pericardium, 5 of 8 (62.5%, P  .126); cryopre-
served pericardium, 2 of 6 (33.3%, P  .796); and PTFE, 3
of 14 (21.4%, P  .135). No specific preoperative demo-
graphic parameter, year, or operation or adjunctive opera-
tive procedure predicted the need for any later intervention
in univariate analysis.
Multivariable logistic regression analysis demonstrated
only use of an autologous pericardial hood to be predictive
of later intervention (P  .04; risk ratio, 10.3; 95% confi-
dence interval, 1.111-95.760). Cox proportional hazard
modeling demonstrated several other predictors of earlier
intervention (Table 5). Although Kaplan-Meier estimates of
TABLE 4. Cox parametric regression of survival free from r
the truncus cohort
Variable
Parameter
estimate SE
Use of valved homograft 1.975111 0.8170
Use of autologous pericardium 2.714667 0.8696
Criteria for assessing model fit (backward elimination provided best model)
12.838; with 2 DF (P  .0016); Wald 2 for covariates, 9.837 with 2 DF (P
TABLE 5. Cox parametric regression of survival free from an
in the truncus cohort
Variable
Parameter
estimate SE
Use of autologous
pericardium
3.338378 0.78311
Use of valved homograft 1.871226 0.67906
Use of bovine
pericardium
1.385416 0.66036
Year of experience 0.196801 0.08229
Age of patient in days –0.034181 0.01609
Criteria for assessing model fit (backward elimination provided best model):
23.045 with 5 DF (P  .0003); Wald 2 for covariates, 20.515 with 5 DF (Pfreedom from any intervention did not demonstrate signif-
The Journal of Thoraciicant differences between VH and DC recipients, statistical
significance was evident when comparing DC recipients
stratified by hood type (P  .0034, Figure 3).
Functional outcomes. No child in the cohort at last
follow-up has demonstrated exercise intolerance. Two chil-
dren are currently being followed for truncal valve insuffi-
ciency, which, although progressive, has not yet warranted
valve replacement.
Discussion
With increased experience and a wider availability of
smaller-sized homografts, many have favored primary re-
pair of the TA in infants and neonates.4-10 Considerable
contention persists, however, as to the optimal method to
establish RV-PA continuity. Reid and colleagues,2 in 1986,
proposed the DC technique later popularized by Barbero-
Marcial and associates3 in 1990. Heralded as a method that
uses autologous tissue (and in theory affords patient
growth), the DC technique has been promoted for its likely
delay (and potential avoidance) of later reoperation. How-
ever, not all reports have been uniformly favorable, and its
use has been questioned because of the valveless connection
created.11 At our institution, availability of homografts of
appropriate sizes for neonatal repairs has not influenced our
operative technique. Instead, we have favored DC, where
anatomically appropriate, in the hopes of avoiding later
conduit exchange; we also observed the need for later CBI
ration for right-sided obstruction (dependent variables) in
Wald 2 P value RR 95% CI
5.84370 .0156 7.207 1.453-35.478
9.74324 .0018 15.100 2.746-83.032
og L—without covariates, 81.586; with covariates, 68.748 2 for covariates,
73). RR, Risk ratio; CI, confidence interval.
tervention for right-sided obstruction (dependent variables)
Wald 2 P value RR 95% CI
18.17303 .0001 28.173 6.071-130.744
7.59348 .0059 6.496 1.717-24.585
4.40151 .0359 3.996 1.095-14.581
5.71910 .0168 1.218 1.036-1.431
4.51059 .0377 0.966 0.936-0.997
g L—without covariates, 34.871; with covariates, 111.827; 2 for covariates,
10). RR, Risk ratio; CI, confidence interval.eope
5
9
:2 Ly in
–2 Loon either the main RV-PA connection or branch PAs.
c and Cardiovascular Surgery ● Volume 129, Number 3 565
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First, VH recipients more frequently required reoperation
for right-sided obstruction than DC recipients. Although all
of the VH recipients receiving repairs in infancy will come
to reoperation, we found it compelling that the DC recipi-
ents did not require as many. Early in our experience, we
tended to use autologous pericardium (both treated and
primarily untreated with gluteralehyde) as a DC hood. As
demonstrated, several of these patients returned early (6
months) for revision of their outflow patch, most often
because of aneurysmal dilatation of the hood. We have since
abandoned use of untreated autologous pericardium (we
continue to use gluteraldehyde-treated autologous pericar-
dium). Therefore eliminating these patients from the DC
cohort likely would make the disparity between VH and DC
recipients more pronounced. Indeed, with the exclusion of
patients with autologous pericardial hoods, only 2 patients
in the DC cohort required reoperation for persistent right-
sided obstruction.
Second, VH and DC recipients required comparable
CBIs for RVOT or PA stenosis. Those patients requiring
CBI early (2 years) after primary operation often required
Figure 3. Kaplan-Meier survival function of freedom fro
by hood type. Five-year survival estimates are illustraadditional CBI or reoperation thereafter. Of those DC re-
566 The Journal of Thoracic and Cardiovascular Surgery ● Marcipients requiring CBI, although 3 (23%) required a second
or third CBI, only 1 ultimately required reoperation. More-
over, the patients with a PTFE hood required CBI late (2, 7,
and 8.5 years) after initial repair. Thus although the DC
technique might not prevent CBI, with appropriate interven-
tion, it can help to reduce later reoperation.
Third, analysis of survival free from either reoperation or
any intervention (CBI or reoperation) demonstrated similar
findings, namely a trend toward improved freedom from
either outcome in the DC group and, within the DC subco-
hort, a statistically significant difference in both outcomes
according to hood material used. However, we were sur-
prised to discover the substantial improvement in results
because of the use of PTFE as hood material. Recent
follow-up echocardiographic findings of both cohorts has
been encouraging. We have followed a policy of aggressive
intervention for branch PA stenosis, and analysis of most
recent echocardiograms demonstrated a low incidence of
significant PA stenosis in both study groups. Free pulmo-
nary insufficiency (also present in one third of the VH
recipients) has been well tolerated by the DC recipients.
Fourth, Cox multivariable analysis of survival free from
y intervention for only those DC patients, as stratified
r patients as a function of type of DC (P  .0034).m anany intervention demonstrated VH and autologous pericar-
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Ddial hood use and year of experience to most strongly
predict any subsequent intervention. The findings related to
year most likely reflect both a recent more aggressive strat-
egy of CBIs in our institution, as well as the increasing
availability of magnetic resonance imaging modalities dis-
closing significant RVOT obstruction earlier.
Finally, our perioperative management of these neonates
appears to have improved significantly. Most of our mor-
tality occurred before 1996, and the majority was caused by
pulmonary hypertension. In recent years, we have favored
the use of nitric oxide in the perioperative period and follow
a policy of paralysis and sedation for all newborns imme-
diately after repair. As others have emphasized, particularly
in the setting of the valveless DC repair, avoidance of major
pulmonary arterial vasoconstriction is essential. Thus assid-
uous mechanical ventilatory management, adequate pulmo-
nary toilet, and the avoidance of atelectasis and consolida-
tion are of utmost importance.2,12-14
We report excellent outcomes with surgical repair of TA
in neonates and infants. When anatomically appropriate, a
DC repair with PTFE demonstrated excellent durability
with a low rate of later interventions. In recent years, CBIs
have substantially reduced the need for reoperation and
remain an essential feature of long-term management. As-
siduous follow-up to guard against progressive ventricular
failure, truncal valve dysfunction, significant disparity in
pulmonary blood flow, or RVOT obstruction is critical, and
early intervention in these settings is warranted.
Several limitations deserve comment. First, this evalua-
tion is subject to the restrictions of a retrospective study;
follow-up was difficult to obtain in patients who had moved
far from the medical center or who had undergone repair in
the distant past. Second, the regularity with which follow-up
echocardiograms were obtained was quite variable. To ad-
just for this, we discarded echocardiographic data acquired
more than 2 years before the study’s end, regardless of the
length of follow-up. Third, the degree to which right-sided
obstruction was interrogated, and thus the potential for its
intervention, remains reliant on the referring physician. Se-
rial echocardiograms performed at regular intervals could
elucidate further the progression of right-sided obstruction
and thereby assist in regulating the process of its interven-
tion.
We thank Mark Russo, MD, MS, for his kind statistical review
of this manuscript.
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Discussion
Dr Constantine Mavroudis (Chicago, Ill). Dr Chen and his
associates have presented their experience with repair of TA in 54
patients, with special consideration to the type of RV-PA conti-
nuity. I would like to congratulate the authors on their excellent
clinical results and, in particular, Dr Chen on a very succinct
presentation. This is a very difficult set of data to present, and I
think you did so masterfully.
I have one comment and a few questions.
I note that you have used the Collett-Edwards classification.
The trend has been to use the Van Praagh classification, which
includes stratification for discontinuous PAs and interrupted aortic
arches. Because you yourself, in this series, have reported 6
patients with interrupted aortic arches, it would seem logical that
you might want to restratify your patient population.
Did your surgical group encounter any cases of discontinuous
PAs, and how were these patients operatively managed?
Also, in those patients with interrupted aortic arches, was the
time interval between primary repair and subsequent conduit re-
vision shorter than in the other patients? And did the aortic arch
repair adversely affect the conduit revision at the time of the
reoperation?
The PTFE hood is somewhat stiff. We use this hood technique
as well, except we use it with a valved conduit to complete the
RV-PA continuity. We believe that this hood maintains its shape
and therefore decreases the chances for stenosis by means of
external compression from either the sternum or the other struc-
tures. I have heard this described as the PTFE hood “fights for its
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Down territory.” Is this your thought, or do you have any other
possible interpretations for this. I think this is a very stark finding
in your report because you have extended the operative interval in
these patients for quite a long time.
Finally, do you have any experience with the Contegra valve
conduit, that is to say, the bovine jugular vein conduit? We have
seen accelerated and early distal stenosis with this graft, and I
believe that Dr Van Garsse will be talking about his experience
from Belgium tomorrow.
Dr Chen. With regard to your first question regarding discon-
tinuous PAs, we had 4 patients who demonstrated that anatomic
diagnosis, and they all fell into the homograft group. One is
certainly less likely to be able to unifocalize discontinuous PAs
and bring them up to the shoulder of the RV without some level of
PA distortion.
With regard to the question about interrupted aortic arch, that
anatomic diagnosis did not acquire significance as a separate risk
factor for subsequent reoperation. And of the entire group, only
one required any kind of patch aortoplasty of the aortic arch. The
arch itself did not adversely affect the later conduit revision, nor
did it need to be repaired itself.
We found the PTFE hood results to be surprising as well. It has
been postulated, of course, that, at the other end of the spectrum,
the pliability of autologous pericardium probably accounts for its
dilatation. Accordingly, one could make the argument that con-
versely the less distensible PTFE might actually allow the trans-
duction of ventricular pressures toward the PA and thereby en-
courage growth and, hopefully, promote less branch PA stenosis,
but that is purely conjecture.
We do not have an independent experience with the Contegra
graft, but I think certainly over the next few years we should be
able to elicit some interesting information from the other centers
where it is being used.
Dr Gerhard Ziemer (Tuebingen, Germany). We were using
the repair without conduit for more than 15 years in a much
smaller program, and I wonder whether you see a difference
between pericardium and PTFE in your outcomes.
My question is this: Do you specifically look at the way you
close your ventricular septal defect, namely, not bringing the
ventricular septal defect patch, because it is sometimes necessary
in the less than 3-kg patient, to the epicardium? Because once you
would do that, then you would have a circumference just consist-
ing of nongrowing tissue. Therefore do you specifically try to put
the ventricular septal defect patch suture strictly endocardially-
intracardially?
Dr Chen. Certainly Dr Quaegebeur might wish to speak to this
as well, but we certainly tried to do that as much as possible. But
I think the other important thing to remember is that the level of
obstruction in the DC recipients generally was not in the proximal
PA. Although there might be that small area of nonviable tissue
adjacent to the ventricular septal defect patch and the patch to the
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or kinked; it seems to be that the obstructions are more distally in
the branch PAs. Therefore certainly, even though that area might
not grow, it does not appear to be a nidus of obstruction.
Dr Ziemer. The DC is really prone to distortion at the bifur-
cation, and therefore this is one of the areas to take care of.
Dr Glen S. Van Arsdell (Toronto, Ontario, Canada). I con-
gratulate you on a beautiful series and a beautiful presentation. The
underlying premise of the surgical strategy is that having pulmo-
nary insufficiency is better than having a conduit that will cause
stenosis and require surgical or catheter reintervention. At least
that is what I would derive from the strategy.
Those of us who have an adult congenital practice have had a
great deal of concern about pulmonary insufficiency, as seen late
in tetralogy of Fallot. I am wondering if you have had an oppor-
tunity to look at these patients in that regard (ie, to look at right
ventricular end-diastolic dimension compared with left ventricular
end-diastolic dimension). In adult congenital patients with pulmo-
nary insufficiency, the bigger the ventricle is, the more likely you
are going to have problems with wide QRS complexes and sudden
death.
Dr Chen. We did not look specifically at the comparison
between right ventricular and left ventricular end-diastolic dimen-
sions. We did look, in the most recent echocardiogram, at the level
or degree of right ventricular dilatation graded as mild, moderate,
and severe. And none of these patients, even those with the free
pulmonary insufficiency, fell into anything other than a mild-to-
moderate status.
But it is a concern. It certainly was a concern of ours regarding
the lack of a valve in this particular scenario. Nonetheless, to date,
our patients appear to be tolerating the pulmonary insufficiency
quite well.
Dr Tara Karamlou (Portland, Ore). I did not notice on your
slides whether you had mentioned whether you were using cryo-
preserved aortic or pulmonary allografts for your reconstruction.
Although truncus is a risk factor in many reports for earlier need
for conduit replacement, I noticed your mean time was just about
9 years, which is a little bit longer than what has been reported in
the literature.
Dr Chen. We used a combination of homografts, almost 50/50
between aortic and pulmonary, and there was no particular char-
acteristic that accounted for one to be chosen over another. More
often, it was availability, more than anything else, and appropriate
sizing that accounted for homograft choice.
Dr Willem J. Daenen (Leuven, Belgium). To avoid PA distor-
tion, we used the Lecompte maneuver, especially in truncus type 2
and 3. Did you use it?
Dr Chen. In none of these patients did we use the Lecompte
maneuver. This strategy has been reported in the literature and
certainly can help to reduce branch PA distortion.
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